Minerva Surgical, Inc.

UTRS

US60343F2056

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 11:02:59 2026-05-20 am EDT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-

24-07-31	From Mammograms to Molecules: Hologic's Quest in Women's Health Tech
24-01-03	Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index	CI

Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Index

Published on 06/23/2023 at 12:00 am EDT

S&P Capital IQ

Add MarketScreener to your sources

MINERVA SURGICAL, INC.

-.--%

Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Index

Add MarketScreener to your sources

Latest news about Minerva Surgical, Inc.

24-07-31	From Mammograms to Molecules: Hologic's Quest in Women's Health Tech
24-01-03	Minerva Surgical, Inc.(OTCPK:UTRS) dropped from S&P TMI Index	CI
23-12-28	Minerva Surgical, Inc.(OTCPK:UTRS) dropped from NASDAQ Composite Index	CI
23-11-13	Minerva Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-11-13	Earnings Flash (UTRS) MINERVA SURGICAL Reports Q3 Revenue $12M	MT
23-10-31	Minerva Surgical, Inc. cancelled the transaction announced on September 28, 2023	CI
23-09-27	Minerva Surgical, Inc. announced that it expects to receive $20 million in funding from Accelmed Partners	CI
23-08-02	Minerva Surgical, Inc., Q2 2023 Earnings Call, Aug 02, 2023
23-08-02	Minerva Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-08-02	Earnings Flash (UTRS) MINERVA SURGICAL Posts Q2 Revenue $13.4M	MT
23-08-02	Minerva Surgical, Inc. Provides Earnings Guidance for the Fiscal Year 2023	CI
23-07-07	Minerva Surgical, Inc. Announces Resignation of Ross A. Jaffe from the Board and from the Compensation Committee of the Board	CI
23-06-23	Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell 3000E Index	CI
23-06-23	Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell Microcap Index	CI
23-06-23	Minerva Surgical, Inc.(NasdaqCM:UTRS) dropped from Russell Microcap Growth Index	CI

Minerva Surgical, Inc. is a medical technology company focused on advancing womenâ€™s health. The Company designs, manufactures, distributes, and commercializes a suite of products that offer effective alternatives to hysterectomy, with a focus on diagnosing and treating the underlying causes of Abnormal Uterine Bleeding (AUB). Its solutions are designed for use across a variety of care settings and focused on improving clinical outcomes and preserve uterine anatomy. It delivers devices that treat the root causes of AUB in both the normal and irregular shaped uterus. The Company's products include Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Operative Hysteroscopy System (Symphion), Resectr Tissue Resection Device (Resectr), and HERizon Disposable Hysteroscope. Its Minerva EAS includes PlasmaSense Technology, which monitors uterine cavity. It also provides HERizon Hysto-Kit, which supports in-office hysteroscopy.

Employees

174

Sector

Medical Equipment, Supplies & Distribution

More about the company